Authors/Disclosures
|
Belen Pascual, PhD
(Houston Methodist Hospital)
|
The institution of Prof. Pascual has received research support from NIH. The institution of Prof. Pascual has received research support from NIH. |
|
Linda Wietecha, RN, MS
(Eli Lilly & Company)
|
Ms. Wietecha has received personal compensation for serving as an employee of Eli Lilly and Company. Ms. Wietecha has received stock or an ownership interest from Eli Lilly and Company. |
|
Paolo Zanotti Fregonara
|
Paolo Zanotti Fregonara has nothing to disclose. |
|
|
No disclosure on file |
|
Quentin Funk
|
Quentin Funk has nothing to disclose. |
|
|
No disclosure on file |
|
|
No disclosure on file |
|
|
No disclosure on file |
|
|
No disclosure on file |
|
|
No disclosure on file |
|
Meixiang Yu
|
No disclosure on file |
|
Bryan M. Spann, DO, PhD
|
No disclosure on file |
|
Paul E. Schulz, MD
(UT Physicians)
|
Dr. Schulz has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Eisa . |
|
|
No disclosure on file |
|
Joseph C. Masdeu, MD, PhD, FAAN
(Houston Methodist Neurological Institute)
|
Dr. Masdeu has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Lilly . The institution of Dr. Masdeu has received research support from NIH. The institution of Dr. Masdeu has received research support from Houston Methodist Foundation. The institution of Dr. Masdeu has received research support from Alector. The institution of Dr. Masdeu has received research support from Aviado-Bio. Dr. Masdeu has received publishing royalties from a publication relating to health care. Dr. Masdeu has received publishing royalties from a publication relating to health care. Dr. Masdeu has received personal compensation in the range of $100,000-$499,999 for serving as a Director, Nantz Nal Alzheimer Center with HOUSTON METHODIST NEUROLOGICAL INSTITUTE. |